Igår publicerades en ny studie från Glyco-gänget. Jag tolkar studien som en säkerhetsstudie mest troligt som svar till EU:s patentverk. De som krånglat med patentgodkännandet. Studien ifråga har undersökt om MIP`sarna har nån påverkan på kroppens immunförsvar. En udda frågeställning,men troligtvis det EU vill ha svar på innan de godkänner patentet. Svaret de kommer få är ett rungande NEJ.
Professor Anette Gjörloff-Wingren med team visar med studien att denna farhåga kan uteslutas.
In conclusion, SA-MIPs have a low degree of inflammatory properties, are not cytotoxic, and can be applicable for future in vivo studies.
Översatt : Sammanfattningsvis har SA-MIPs en låg grad av inflammatoriska egenskaper, är inte cytotoxiska och kan användas för framtida in vivo-studier. (in-vivo = inne i kroppen)
För att verkligen komma till botten med denna fråga har teamet varit flitiga i att använda HoloMonitor.
digital holographic cytometry (DHC) = HoloMonitor
Men till studien som är betitlad :
Published: 15 June 2022
Abstract
Molecularly imprinted polymers (MIPs) against sialic acid (SA) have been
developed as a detection tool to target cancer cells. Before proceeding
to in vivo studies, a better knowledge
of the overall effects of MIPs on the innate immune system is needed.
The aim of this study thus was to exemplarily assess whether SA-MIPs
lead to inflammatory and/or cytotoxic responses when administered to
phagocytosing cells in the innate immune system. The response of
monocytic/macrophage cell lines to two different reference particles,
Alhydrogel and PLGA, was compared to their response to SA-MIPs. In vitro
culture showed a cellular association of SA-MIPs and Alhydrogel, as
analyzed by flow cytometry. The reference particle Alhydrogel induced
secretion of IL-1β from the monocytic cell line THP-1, whereas almost no
secretion was provoked for SA-MIPs. A reduced number of both THP-1 and
RAW 264.7 cells were observed after incubation with SA-MIPs and this was
not caused by cytotoxicity. Digital holographic cytometry showed that
SA-MIP treatment affected cell division, with much fewer cells dividing.
Thus, the reduced number of cells after SA-MIP treatment was not linked
to SA-MIPs cytotoxicity. In conclusion, SA-MIPs have a low degree of
inflammatory properties, are not cytotoxic, and can be applicable for
future in vivo studies.
1. Introduction
Nanoparticle-assisted
cancer detection and monitoring have the potential for wider use in
tumor diagnostics and treatment. We and others have previously
investigated molecularly imprinted polymers (MIPs) that target different
structures, such as glycans, peptides or proteins on the cell surfaces.
Specifically, the monosaccharide sialic acid (SA) has been the focus of
many studies, due to its role as a potential cancer biomarker. SA-MIPs have been demonstrated to target different cell lines in vitro, as shown by flow cytometry and cell imaging experiments. MIPs have also been frequently used and investigated in vivo, with promising results for both targeting and drug delivery. However, to continue using MIPs in vivo, further information regarding the overall effects of MIPs on the innate immune system is needed.
It
is well documented that the physicochemical properties of nano- and
submicron-sized particles are likely to influence their biological fate
and actions of the particles in vivo.
Nanoparticles often aggregate under physiological conditions, and it is
known that aggregates of nanoparticles of an intermediate size (1–5 µm)
are phagocytosed more readily than smaller or larger particles.
At physiological conditions, phagocytosis of synthetic particles by
monocytes and macrophage-derived cells plays a significant role in
determining the fate of delivery systems utilizing nanoparticles. Phagocytosis is responsible for the failure of many drug delivery strategies using nanoparticles in vivo due to undesirable immune cell targeting.
Moreover, protein adsorption to the surface due to the surface charge
of the particles affects the interaction with the cells. If particles are removed by macrophages before reaching their intended destination in vivo
they can induce an inflammatory response due to their interaction with
phagocytosing cells. Therefore, understanding and monitoring
nanoparticle phagocytosis by immune cells is critical for developing
these particles for successful use in vivo.
Most
leukocytes, including monocytes and macrophages express SA, and thereby
SA-MIPs will target SA on those cells. The aim was to study the general
impact of MIPs on the innate immune system regarding phagocytosing
cells, using SA-MIPs. To study the impact of SA-MIPs on phagocytic
cells, the monocytic/macrophage cell lines THP-1 and RAW 264.7 were
chosen as classical phagocytosing cells. THP-1 and RAW 264.7 cells have
both been extensively used to study macrophage functions, mechanisms,
signaling pathways, and drug transport.
SA-MIPs show the potential to interact with the cells, thus it is
relevant to use SA-MIPs together with two different and
well-characterized reference particles; aluminum adjuvant in the form of
Alhydrogel® and poly(lactic-co-glycolic acid) (PLGA), for interaction studies with phagocytosing cells.
Inflammatory
responses, elicited by nanoparticles, in particular, are important to
control, since constant or hyperstimulation can result in chronic
diseases.
Macrophages are central mediators of innate immunity linked to chronic
inflammation including anti-oxidative and pro-inflammatory responses as
well as cell death.
The reference particles Alhydrogel and PLGA were used to compare the
possible inflammatory response and cytotoxicity caused by the SA-MIPs.
To evaluate any inflammatory response by the SA-MIPs and the reference
particles, induction and secretion of the pro-inflammatory cytokines
IL-1β, TNF-α and IL-6 were investigated.
Cell
proliferation upon culture in the presence of SA-MIPs was scrutinized
using digital holographic cytometry (DHC). DHC is a non-phototoxic
quantitative phase imaging technique that enables the monitoring of
living cells.
The DHC technique allows for long time monitoring of the cells,
acquiring high time resolution images, which can be used for
longitudinal tracking of individual cells.
Tracking of individual cells using DHC demonstrated that the SA-MIPs
had an impact on cell proliferation and cell division, but the reduction
in cell numbers could not be attributed to SA-MIPs cytotoxicity.
Materials and Methods
2.13. Digital Holographic Cytometry (DHC) and Cell Tracking
RAW 264.7 cells were seeded in a Sarstedt lumox® 96-well plate (Sarstedt, Germany) with 2 × 104 cells per well and incubated overnight at 37 °C with 5% CO2
allowing the cells to adhere. The medium in each well was renewed with
either 40 µg/mL SA-MIPs, for treated cells, or culture medium for
untreated cells. The lid was changed to Hololids for 96-well plates
(PHIAB, Lund, Sweden), which enable cell imaging by the HoloMonitor M4
digital holographic cytometer (DHC) (PHIAB). The plates were placed on
the motorized stages of HoloMonitor M4 in a standard 37 °C with 5% CO2
incubator. Triplicated experiments were performed using 2 wells of
treated and untreated cells in each experiment. Five positions in each
well were chosen and images captured every 15 min for 48 h. Time-lapse
imaging, image processing, segmentation and analysis were conducted with
the App Suite software package (v3.5.0, PHIAB, Lund, Sweden) based on
absolute values of refractive indexes for cells and culture medium. As
the laser intensity is approximately 10 W/m2 during imaging,
and exposure time is less than 10 ms, it is assumed that the laser
irradiation has only minimal effect on the physiological functions of
the cells. App Suite was used for the tracking of individual cells. For
each capturing position, cells were selected at time-point 0 h, which is
the first image acquired in the 48 h time-lapse. When the cells
divided, the two daughter cells were selected for further analysis and
connected to the mother cell. This enables the calculation of the time
of each cell division for individual cells.
Based on known time-points for cell divisions and from which cell the
daughter cells originated, a cell family tree was drawn for each cell
selected at time-point 0 h using RStudio software (v.2021.09.1, RStudio,
Boston, MA, USA).
Real-time holographic images were captured every 15 min during 48 h of
RAW 264.7 cells cultured in the presence or absence of SA-MIPs. Examples
of holographic images of cells incubated with 0 µg/mL SA-MIPs and 40
µg/mL SA-MIPs from a randomly selected area in the culture well at the
first and last time-point of the time-lapse are shown (Figure 6a,
b). SA-MIPs (40 µg/mL) were cultured together with RAW 264.7 cells for
up to 48 h and the cell number was determined using DHC (Figure 6c).
More than twice as many cells were identified in samples with cells
grown in a culture medium only after 48 h compared to cells cultured in
the presence of SA-MIPs.
5. Conclusions
We
have demonstrated that SA-MIPs induced low induction and secretion of
inflammatory cytokines that were comparable to phagocytosing cells
cultured in the presence of the reference particles Alhydrogel and PLGA.
The reduced number of cells upon incubation with SA-MIPs was not due to
cytotoxicity but due to an attenuated cell cycle caused by the presence
of the SA-MIP. The effects on the cell cycle were observed using a
longitudinal investigation of individual cells and the results support
the hypothesis that phagosomes also have regulatory functions with
regard to the cell.
In summary, this suggests that synthesized MIPs would be applicable for future in vivo studies based on the low in vitro cytotoxicity and mild inflammatory properties of the SA-MIPs used in this study.
Min kommentar
Om mitt antagande stämmer (är 99% säker) har nu EU:s patentverk fått svar på de frågeställningar som var hindret för ett patentgodkännande.Med detta antagande kan vi se fram mot ett snyggt paketerat PM inom kort. Sannolikt kommer även Kina ge sitt godkännande samtidigt.
Paket-PM = EU + Kina godkänner patentet.
Efter alla patent är godkända (USA,Japan,EU och Kina) väntar spännande tider.
Ska PHI ragga bjässepartner för att närma sig marknad med GlycoImaging?
Eller kommer andra bjässar (tillverkande medicinbolag) vilja köpa loss det?
Som sagt,spännande tider väntar.
Tack till Oscar som hittade denna info och var vänlig att mejla över den.
Inga kommentarer:
Skicka en kommentar